
Rahul Singhvi, Resilience CEO (Business Wire)
Resilience purchases Ohio biomanufacturing site from AstraZeneca
Biotech manufacturing pioneer Resilience said Tuesday afternoon that it is purchasing an Ohio-based manufacturing site from AstraZeneca and building a new partnership with the UK-based pharma.
The facility is based in the town of West Chester, OH, just north of Cincinnati. Resilience will produce “select” AstraZeneca medicines at the facility as part of the supply agreement. The financial terms of the agreement weren’t disclosed, but the deal is expected to close early next year.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters